Found: 24
Select item for more details and to access through your institution.
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 931, doi. 10.1007/s00280-008-0681-2
- By:
- Publication type:
- Article
Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 937, doi. 10.1007/s00280-008-0683-0
- By:
- Publication type:
- Article
Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 949, doi. 10.1007/s00280-008-0684-z
- By:
- Publication type:
- Article
Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 959, doi. 10.1007/s00280-008-0685-y
- By:
- Publication type:
- Article
BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 965, doi. 10.1007/s00280-008-0686-x
- By:
- Publication type:
- Article
Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 977, doi. 10.1007/s00280-008-0687-9
- By:
- Publication type:
- Article
Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 985, doi. 10.1007/s00280-008-0688-8
- By:
- Publication type:
- Article
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 995, doi. 10.1007/s00280-008-0689-7
- By:
- Publication type:
- Article
Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1009, doi. 10.1007/s00280-008-0690-1
- By:
- Publication type:
- Article
Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1015, doi. 10.1007/s00280-008-0691-0
- By:
- Publication type:
- Article
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1027, doi. 10.1007/s00280-008-0692-z
- By:
- Publication type:
- Article
Topotecan distribution in an anephric infant with therapy resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1039, doi. 10.1007/s00280-008-0694-x
- By:
- Publication type:
- Article
Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1045, doi. 10.1007/s00280-008-0695-9
- By:
- Publication type:
- Article
Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1055, doi. 10.1007/s00280-008-0697-7
- By:
- Publication type:
- Article
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL™), a multi-targeted kinase inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1065, doi. 10.1007/s00280-008-0699-5
- By:
- Publication type:
- Article
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCELtrade mark), a multi-targeted kinase inhibitor.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1075, doi. 10.1007/s00280-008-0700-3
- By:
- Publication type:
- Article
Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1085, doi. 10.1007/s00280-008-0709-7
- By:
- Publication type:
- Article
Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1091, doi. 10.1007/s00280-008-0771-1
- By:
- Publication type:
- Article
A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1103, doi. 10.1007/s00280-008-0693-y
- By:
- Publication type:
- Article
Tumor resensitization to erlotinib following brief substitution of cetuximab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1111, doi. 10.1007/s00280-008-0698-6
- By:
- Publication type:
- Article
Is oncogenesis a normal cellular defense mechanism?
- Published in:
- 2008
- By:
- Publication type:
- Letter
Professor Lloyd R. Kelland: man of science.
- Published in:
- 2008
- By:
- Publication type:
- Obituary